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Abstract OBJECTIVE: Microinjectin of neostigmine, an inhibitor of acetylcholine esterase, 
into the rat hippocampus elicited stress-like responses reﬂ  ected by the release of 
adrenocorticotropic hormone (ACTH) and blood glucose elevations. Th  e  ento-
rhinal cortex is regarded as an interface between the hippocampus and neocor-
tex. Th   e current study was designed to examine the role of the entorhinal cortex 
in regulation of blood glucose elevation induced by hippocampal neostigmine 
injection. 
MARERIAL AND METHODS: We produced the entorhinal cortex lesions in 9 week-
old male Wistar rats by the bilateral injections of the cell-selective neurotoxin, 
ibotenic acid (15 µg / µl). Two weeks aft  er the injections, neostigmine methylsul-
fate (sigma, 5x10–8 mol) was microinjected into the rat hippocampus in a volume 
of 1 µl for 1 min using a CMA/100 microinjection pump.Plasma ACTH levels 
were measured by radioimmunoassay. Plasma glucose concentrations were deter-
mined by the immobilized enzyme membrane/H2O2 method with a compact glu-
cose analyzer Antsense II (Bayer Medical Co.Ltd,Tokyo, Japan). 
RESULTS: Compared with sham-operated control rats, the entorhinal lesions pro-
duced by ibotenic acid signiﬁ  cantly attenuated the elevations of blood glucose 
evoked by the microinjection of neostigmine into the hippocampus. However, no 
signiﬁ  cant diﬀ  erence of plasma ACTH in response to the injection was observed 
between the entorhinal-lesioned rats and controls. 
CONCLUSION: Th   e results of the present study indicate that the entorhinal cortex 
plays a role in the central nervous systems regulation of blood glucose and may be 
involved in a stress response presumably via an alternative pathway.226 Neuroendocrinology Letters No.3 June Vol.26, 2005 Copyright © Neuroendocrinology Letters ISSN 0172–780X   www.nel.edu
Abbreviations:
ACTH    adrenocorticotropic hormone
EC      entorhinal cortex
CNS      central nervous systems
CRH      corticotropin releasing hormon
PVN     paraventricular nucleus
HPA      hypothalamic-pituitary-adrenal
BNST     bed nucleus of the stria terminalis
Introduction
Stress is common to all living creatures regardless 
of diﬀ  erences in its quality or intensity. Th  e  imposition 
or perception of environmental or physical change, 
negative or positive, elicits a spectrum of physio-
logic changes that can be construed as adaptive to 
the organism. Prominent among these is the release 
of glucocorticoids by the adrenal glands, which serves 
to alert the organism to environmental or physiologic 
changes and to preserve homeostasis. Levine and 
Ursin [10] provided a deﬁ  nition of stress that con-
sists of three elements: stimulus input, central pro-
cessing system, and response output; with biological 
and psychological processes viewed as integral parts 
of the general homeostatic principle. Th   e brain per-
ceives inputs of various stressors and responds via the 
nervous, endocrine and immune systems, which are 
called stress responses [17]. In this sense, the brain 
plays a role in governing the stress responses. Ele-
vations of corticotropin-releasing factor, ACTH and 
glucocorticoids are the main features of reactions 
to diverse and acute stressful stimuli [2, 24]. During 
stress, neurons of the hypothalamic paraventricular 
nucleus (PVN) release corticotropin-releasing hor-
mone into the pituitary portal circulation, and ACTH 
secreted from the anterior pituitary gland in response 
to corticotropin-releasing hormone, stimulates the 
secretion of glucocorticoids from the adrenal gland. 
Th  is constitutes the hypothalamic-pituitary-adrenal 
(HPA) axis, which is the major regulator of neuroen-
docrine stress responses [1,5,7,11,13,15]. Involvement 
of the limbic system in neuro-endocrine responses to 
some stressors has been documented. A wealth of evi-
dence suggests that the hippocampal cholinergic sys-
tem is involved in some stress responses [9,12,21]. In 
particular, the cholinergic system in the hippocampus 
plays a role in regulating the peripheral metabolism of 
glucose and catecholamines [7,21]. Under stress, the 
release of acetylcholine in the hippocampus increases, 
which coincides with the elevation of plasma glucose 
and catecholamines [19]. In our previous experiments, 
we observed that the administration of neostigmine, 
an acetylcholine esterase inhibitor, into the hippocam-
pus elevates the levels of blood glucose and ACTH. 
Th  us, we concluded that the microinjection of neo-
stigmine into the hippocampus is a potential exper-
imental model for acute stress responses [7,8]. Th  e 
entorhinal cortex is a gateway to the hippocampus. 
Many sensory inputs and other information reach 
the hippocampus via the entorhinal cortex. It receives 
inputs from the neocortex, including the temporal 
and frontal lobes, amygdala and olfactory bulbs [3]. 
Information enters the hippocampal formation via the 
entorhinal cortex and exits via the fornix. Also, the 
entorhinal cortex is the primary supplier of converg-
ing neocortical sensory input to the ipsilateral dentate 
gyrus of the hippocampal formation [20]. We previ-
ously reported on the involvement of the entorhinal 
cortex in the stress response to immobilization [22]. 
Lesions in this area produced by ibotenic acid attenu-
ate ACTH elevation during immobilization stress but 
not during insulin-induced hypoglycemia. Th  e aim 
of this study was to investigate the role of the ento-
rhinal cortex in stress responses. We produced bilat-
eral entorhinal lesions using ibotenic acid in rats, and 
observed the peripheral responses of stress markers 
induced by microinjections of neostigmne into the 
hippocampus.
Material and Methods
Subjects:  We used 9 week-old male Wistar rats 
(200–300 g) for the experiment. Th  e animals were 
individually housed under standard laboratory con-
ditions in temperature-controlled rooms (25 °C), and 
were maintained under a 12 h light/dark cycle (light 
on at 06.00) with food pellets and water available ad 
libitum. Th   e rats were cared for in accordance with the 
ethical guidelines approved by the Animal care and 
Use Committee of Nagoya University.
Experimental protocol: Rats were randomly assigned 
to one of two major groups: unlesioned or lesioned.
Th   e rats in each group were then divided into two 
subgroups: Group 1: unlesioned neostigmine-injected, 
Group 2: unlesioned saline-injected, Group 3: lesioned 
neostigmine-injected, and Group 4: sham-operated 
rats, neostigmine-injected.
Surgery: Th  e rats were anesthetized with sodium 
pento  barbital (50 mg/kg i.p.) and mounted in a ste-
reotaxic frame (Narishige Scientiﬁ  c Instruments Lab-
oratory, Tokyo, Japan). For insertion of the stainless 
steel needle, the skull was exposed and a burr hole was 
drilled overlying the injection coordinates. Ibotenic 
acid was injected through a stainless steel needle (out-
side tip diameter of 28 µm), which was connected to a 
1.0 µl syringe via a 30 cm tube ﬁ  lled with the injection 
solution. Coordinates for the entorhinal cortex were 
calculated relative to Bregma with the incisor bar set 
at –3.30 mm. Th   e coordinates used were anterior-pos-
terior –6.04 mm, medial-lateral ±6.50 mm and dorsal-
ventral 7.00 mm from the skull surface in accordance 
with the atlas of Paxinos and Watson [14]. Entorhinal 
cortex lesions were produced by pressure-injection of 
0.1 µl of ibotenic acid (15 µg / µl in 0.9% NaCl, Sigma 
Chemical Co., St Louis, MO, USA) bilaterally over 5 
min. Th   e tip was allowed to remain in the brain for 5 
min aft  er injection to minimize dorsal diﬀ  usion of the 
drug along the needle tract. Sham-operated rats were 
treated in an identical manner to the ibotenic acid-
lesioned rats but were injected with the same volume 
of saline without ibotenic acid.
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A recovery period of 7 days was given to the above 
operated rats (Group 3, 4), otherwise all rats were 
anesthetized one week before the experiment to ste-
reotaxically implant a guide cannula (Bas, Tokyo, 
Japan) into the left   dorsal hippocampus at the follow-
ing coordinates: anterior-posterior –2.0 mm, medial-
lateral 1.5 mm, dorsal-ventral 3.5 mm in accordance 
with the Paxinos and Watson atlas [14] one week 
before the experiments.
Th   e day before the experiments, the rats were anes-
thetized with diethyl ether (Kanto Chemical Co. Inc, 
Tokyo, Japan), and a catheter was inserted into the 
jugular vein for repeated blood sampling. A 2 cm lon-
gitudinal incision was made in the neck directly over 
the trachea. Th   e underlying muscles were separated 
using blunt dissection and the right jugular vein was 
catheterized with Silastic tubing (Shiniest Polymer, 
Nagoya, Japan) ﬁ  lled with heparinized saline. Th  e 
catheter was threaded through the vein over a dis-
tance of 2.5 cm, which allowed the tip of the cannula 
to rest in or near the atrium. Th   e free end of the cath-
eter was plugged with a knot and the catheter exteri-
orized and secured at the back of the neck with a spe-
cial cap.Th   e rats were kept in individual cages with 
free access to water and food.
Procedures: Two weeks aft  er developing entorhinal 
cortex lesions, saline containing neostigmine meth-
ylsulfate (sigma, 5x10–8 mol) was microinjected in a 
volume of 1µl for 1 min using a CMA /100 microin-
jection pump (BSA, Tokyo, Japan) through the guide 
cannula into the left   dorsal hippocampus of free mov-
ing rats. To determine the plasma concentration of 
ACTH and glucose, blood was intermittently sam-
pled (0.8 ml), starting at time 0, just before injection, 
and at 10, 30, 60 and 120 min aft  er. To minimize the 
eﬀ  ect of volume loss, an equal volume of heparinized 
saline was retuned to the general circulation at each 
sampling. Th   e blood samples were kept on ice, cen-
trifuged, and the plasma was removed and stored at 
–20 °C in 400 µl aliquots for subsequent determina-
tion of ACTH by radioimmunoassay [16]. Plasma glu-
cose concentrations were determined by the immo-
bilized enzyme membraine/H2O2 method with a 
compact glucose Antsense II analyzer (Bayer Medi-
cal Co. Ltd, Tokyo, Japan) (21). All experiments were 
completed between 10.00 h and 13.00 h to mini-
mize variability resulting from circadian rhythm. 
Two hours aft  er neostigmine injection, the rats were 
deeply anesthetized with a lethal dose of sodium pen-
tobarbital and transcardially perfused with saline fol-
lowed by 4% paraformaldehyde in 0.1 M phosphate 
buﬀ  er (pH 7.4). Th  ey  were  postﬁ  xed over night and 
cryoprotected in phosphate-buﬀ  ered saline contain-
ing 30% sucrose for 2 days.
Histological veriﬁ  cation:  For the veriﬁ  cation  of 
lesions and the eﬀ  ect of the vehicle, the postﬁ  xed 
brains were frozen with powdered dry ice and serial 
sections 20 µm in thickness were processed from the 
region of the entorhinal cortex and mounted on glass 
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slides. Selected regions were stained with Cresyl Vio-
let to assess the extent of the lesions in the entorhi-
nal cortex.
Data and statistical analysis: All sections were 
assessed by means of microscopic examination using 
an Olympus BX50 microscope (Tokyo, Japan). Photo-
graphs were made of representative lesions and vehi-
cle injection sites in the entorhinal cortex. Blood glu-
cose concentrations were expressed as means ±S.E.M, 
and diﬀ  erences between the four experimental groups 
were assessed using repeated measures of one factor 
ANOVA. Plasma ACTH levels were measured by 
radioimmunoassay [16], and plasma glucose concen-
trations were determined by the immobilized enzyme 
membrane/H2O2 method with a compact glucose 
Antsense II analyzer (Bayer Medical Co. Ltd, Tokyo, 
Japan) [18].
Results
Figure 1 shows Nissle staining of representative 
sections including the entorhinal cortex. Th  e  signif-
icant loss of neurons accompanied by extensive glial 
proliferation was observed in the entorhinal cortex 
sections of animals that received ibotenic acid injec-
tions (Group 3) (Fig. 1D,E). Animals that received 
injections of vehicle in the entorhinal cortex did not 
show any histological signs of neuronal damage (Fig. 
1B,C). Figure 2 shows the ACTH and blood glucose 
concentrations for the lesoined and unlesioned rats 
following microinjectin of neostigmine into the hip-
pocampus. Figure 2A shows the blood glucose con-
centration aft  er microinjection of neostigmine into 
the hippocampus. For Group 1, the plasma concen-
tration of glucose increased aft  er 10 min and reached 
a peak aft  er 60 min. Th   e saline injected group (Group 
2) showed no eﬀ  ect. For the lesioned groups, blood 
glucose levels for Group 3 were signiﬁ  cantly lower 
than those of Group 4 (Fig. 2A). ANOVA showed 
that there was a statistically signiﬁ  cant  diﬀ  erence 
among the groups (p<0.0001), and Scheﬀ  e’s post–hoc 
analysis indicated that ibotenic acid lesions signiﬁ  -
cantly attenuated blood glucose release evoked by the 
microinjection of neostigmine into the hippocampus 
(Fig. 2A). No signiﬁ  cant diﬀ  erence was observed in 
the plasma ACTH concentration between Group 1, 3 
and 4 aft  er the microinjection of neostigmine into the 
hippocampus (Fig. 2B).
Discussion
In the current study, we have discovered that the 
entorhinal cortex is involved in the regulation of 
stress-like responses induced by hippocampal neo-
stigmine injection. Th  e lesions in this area signiﬁ  -
cantly attenuated the blood glucose elevation but did 
not aﬀ  ect ACTH secretion. No signiﬁ  cant diﬀ  erence 
of weight was observed before and aft  er lesion.
During stress, an adaptive or compensatory res-
ponse by the organism is activated to sustain homeo-
stasis. Stress induces adaptation through the produc-228 Neuroendocrinology Letters No.3 June Vol.26, 2005 Copyright © Neuroendocrinology Letters ISSN 0172–780X   www.nel.edu
Figure 1.
(A): Schematic representation of a bilateral entorhinal cortex lesion.
Photomicrographs of coronal sections through the entorhinal cortex stained with Cresyl violet illustrating the extent of damage:
(B) Vehicle injection into the entorhinal cortex. (C) Enlarged view of that shown in (B). 
(D) Ibotenic acid injection into the entorhinal cortex. (E) Enlarged view of that shown in (D). 
The section was sampled from the injection sites where the maximal amount of cell damage was observed.
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tion of various mediators such as adrenal steroids, 
catecholamines, cytokines, and tissue mediators [13]. 
Stress-related signals in the central nervous system 
initially act upon the hypothalamus. From there, sig-
nals, which respond to stress stimuli in the central 
nervous system, reach the peripheral nervous system 
through several pathways. Two main ones are; (1) 
autonomic neurons and the adrenal medulla system, 
which release catecholamines; and (2) the hypotha-
lamic-pitutitary-adrenal system, known as the HPA 
axis, which releases glucocorticoids. Th  e  secretion  of 
adrenocortical glucocorticoids is driven by the release 
of ACTH from corticotropes in the anterior pituitary 
gland. Neurons in the PVN are the most potent struc-
tures capable of inducing ACTH release in response 
to stress through the release of corticotropin-releas-
ing factor [24].
Microinjections of neostigmine into the hippocam-
pus produce hyperglycemia associated with the secre-
tion of plasma cathecholamines, which showed simi-
larities to stress responses. Regarding the mechanism 
responsible for the neostigmine-induced elevation 
of plasma glucose, at least four pathways had been 
hypothesized; (1) secreted epinephrine may directly 
act on the hepatic release of glucose, (2) epinephrine 
may induce the release of glucagon, (3) direct neu-
ronal control in the pancreas causes glucagon secre-
tion, (4) direct innervation in the liver induces glucose 
release [6]. Our previous studies showed that ACTH 
release is accompanied by c-fos expression, a univer-
sal marker of neuronal activation, in the PVN of the 
hypothalamus [24]. We also found that the bed nucleus 
of the stria terminalis (BNST) is involved in the reg-
ulation of ACTH release in response to hippocampal 
neostigmine injection [4,23]. Th  is  structure  receives 
inputs directly from the ventral hippocampus area 
and sends a heavy axonal projection into neuroendo-
crine cell regions of the PVN [5,23]. Although lesions 
of the BNST attenuated the elevation in ACTH, and 
c-fos expression in the PVN induced by hippocam-
pal neostigmine injection, blood glucose elevation 
was not altered by the BNST lesions [23,24]. Th  is  sug-
gests that glucose and ACTH are regulated diﬀ  erently 
within the brain, and that BNST is not involved in the 
glucose regulation pathways.
Th   e entorhinal cortex occupies a key position in the 
limbic system, functioning as a relay station between 
the hippocampus and neocortex. Th  e  entorhinal  cor-
tex is a major gateway for sensory information into 
the hippocampal formation. In the current study, the 
entorhinal cortex lesion attenuated blood glucose ele-
vation but did not aﬀ  ect the ACTH response. Th  ese 
results suggest that the entorhinal cortex plays role 
in blood glucose regulation and not in ACTH regu-
lation when the hippocampal cholinergic system is 
activated.
We previously found that the entorhinal cortex is 
involved in the stress response to immobilization but 
Figure 2. 
Plasma ACTH and blood glucose concentrations 
in rats microinjected by neostigmine into the 
hippocampus.
(A) Blood glucose concentrations. Repeated 
ANOVA showed that entorhinal-lesioned rats 
had significantly lower concentrations than 
unlesioned rats (p<0.0001)
, Group 1: unlesioned neostigmine-injected (n=6); 
, Group 2: unlesioned saline-injected (n=5); 
, Group 3: lesioned neostigmine-injected (n=11); 

, Group 4: sham-operated, neostigmine-injected 
(n=6).
(B) Plasma ACTH concentrations. Repeated ANOVA 
showed no significant difference between 
entorhinal lesioned rats and rats who had saline 
injected into the entorhinal cortex.
, Group 1 unlesioned neostigmine-injected (n=6); 
, Group 2: unlesioned saline-injected (n=5); 
, Group 3: lesioned neostigmine-injected (n=6); 

, Group 4: sham-operated, neostigmine-injected 
(n=5).
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not to insulin-induced hypoglycaemia [22]. Lesions in 
this area attenuate ACTH release induced by immo-
bilization but have no eﬀ  ect on the blood glucose 
response. Th  ese  ﬁ  ndings are not compatible with what 
we observed in this study using hippocampal neostig-
mine injections. Although the hippocampal neostig-
mine–injection model shows similarities to the stress 
responses in terms of ACTH and glucose proﬁ  les in 
the plasma, the model may activate a pathway in the 
brain diﬀ  erent from what is activated in response to 
immobilization.
Recent evidence suggests that various stressors 
activate diﬀ  erent regulatory pathways. According to 
Herman and Cullinan [5], stressors can be divided 
into two categories. One category is processive (emo-
tional/ psychological) stressors, which activate cor-
tical and limbic areas before the PVN is activated. 
Signals from multiple sensory modalities are pro-
cessed in these structures prior to ﬁ  nal elaboration 
of the stress response. Th  e other group is systemic 
(physical) stressors, which directly threaten the sur-
vival and activate the PVN through the ascend-
ing catecholaminergic pathway from the brainstem. 
According to Herman and Cullinan’s deﬁ  nition immo-
bilization stress is processive stress. Since the brain 
pathways activated in the hippocampal neostigmine-
injection model were diﬀ  erent from the responses 
to immobilization, this model may show similari-
ties to other types of stress responses. Further inves-
tigation should be performed to elucidate the mech-
anism responsible for this. In conclusion, the present 
study showed the role of entorhinal cortex in regulat-
ing stress response induced by microinjection of neo-
stigmine and the relationship between the entorhinal 
cortex and hippocampus in stress responses.
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